Québec, Canada – August 31, 2023 – OPTEL, the worldwide leader in supply chain traceability solutions, today announced the launch of its groundbreaking end-of-line automation solution for pharmaceutical manufacturers, the Cobot Palletizer.
OPTEL’s Cobot Palletizer is a game-changer that will help resource-strapped production teams with repetitive and manual tasks, such as feeding or removing pallets, by automating the entire process. This frees up staff for more value-added tasks that can better impact a pharmaceutical company’s bottom line.
The Cobot Palletizer can be seamlessly integrated into existing production lines, making it easy and fast to implement without any major downtimes.
An added bonus? The Cobot Palletizer has been designed to work with OPTEL’s serialization solutions, which is a clear advantage for pharmaceutical manufacturers looking to accelerate their system interoperability compliance for the United States FDA’s looming Drug Supply Chain Security Act (DSCSA), which comes into effect in November 2023 and violations being sanctioned as of November 2024.
At Optel, innovation and truly understanding the pharmaceutical industry’s major challenges has always been part of our DNA. We continuously strive to develop revolutionary, yet pragmatic and reliable, solutions that exceed clients’ expectations and requirements.
OPTEL is a leading global provider of traceability systems whose goal is to use its innovative technologies to build a sustainable world through the Intelligent Supply Chain. OPTEL is the only company with the ability to offer complete end-to-end traceability, providing granular data at every step of the supply chain—from raw materials to the consumer and beyond. Founded in 1989, OPTEL is a Certified B Corporation headquartered in Canada, with facilities in Ireland, India and Brazil, as well as employees worldwide. For more information, visit optelgroup.com.